Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

U.S. News

University of Alabama Wins $16 Million Grant to Develop Possible HIV Vaccine

August 12, 2003

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!

The National Institute of Allergy and Infectious Diseases has awarded a $16 million grant to the University of Alabama-Birmingham to fund HIV vaccine development efforts. In a news release yesterday, UAB announced it has been chosen to lead the 4.5-year study, which will also be conducted at Harvard and Emory universities and at Novavax Inc. The team will develop and test a vaccine in animals, then conduct a small-scale study of the vaccine in humans. UAB professor of microbiology and medicine Dr. Jiri Mestecky will lead the study.

Back to other news for August 12, 2003

Adapted from:
Associated Press
08.12.03

A note from TheBody.com: Since this article was written, the HIV pandemic has changed, as has our understanding of HIV/AIDS and its treatment. As a result, parts of this article may be outdated. Please keep this in mind, and be sure to visit other parts of our site for more recent information!



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 
See Also
More News and Analysis on Vaccines for HIV Prevention
Advertisement:
Find out how a Walgreens specially trained pharmacist can help you

Tools
 

Advertisement